Nearly 30 years after it began, a study of prostate cancer patients shows both that the disease will not cause harm to the majority of men who have it, and that aggressive treatment is warranted for men with an intermediate risk of spread.
Some day, an academic historian will write the definitive history of how, in the late 20th and early 21st centuries, American politics became so thick with medical doctors who ascribe to crazy ideas. First among them, of course, will be former Congressman Paul Broun of Georgia, who told a local sportsmen's banquet back home that everything he'd learned in medical school was a tool of the devil in one way or another.
Nobody wants to spend the holidays in the hospital. But patients who are discharged from the hospital during the holidays have a higher risk of death or readmission, according to new research. The study, published in The BMJ medical journal, found that people tend to be discharged more quickly at this time of year so they can be home with their families. Reduced staffing and lack of follow-up care may also play a role, the researchers say.
Dr. Jonathan Sevransky was intrigued when he heard that a well-known physician in Virginia had reported remarkable results from a simple treatment for sepsis. Could the leading cause of death in hospitals really be treated with intravenous vitamin C, the vitamin thiamine and doses of steroids?
Patients and relatives of those treated at a famous research hospital in New York want to know why Rockefeller University stayed quiet about a prominent doctor who died 11 years ago and is believed to have abused children for decades. Attorneys representing those individuals now say there may be over 1,000 victims in what may be the largest case of sexual abuse by one person in U.S. history.
Americans pay more than other countries do for prescription drugs, and see quicker drug approvals — but not necessarily better health outcomes, according to several studies. Why it matters: As Washington debates the administration’s new Medicare drug pricing proposal, the pharmaceutical industry says high U.S. drug prices are justified because we have better access to new drugs.